Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer

NCT00434668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: cisplatin/docetaxel
DRUG: cisplatin/vinorelbine

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]
[object Object]